The global market for acute agitation and aggression drugs is booming, projected to reach $1398.1 million by 2025, with a 5% CAGR. Driven by rising mental health disorders and aging populations, this market is segmented by administration (oral, injection), application (hospitals, psychiatric facilities), and key players like Eli Lilly and Pfizer. Explore market trends and forecasts for 2025-2033.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
